latrepirdine has been researched along with Protein Aggregation, Pathological in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cano-Cuenca, N; Jordán, J; Solís-García del Pozo, J | 1 |
| Bachurin, S; Shevtsova, E; Ustyugov, A | 1 |
2 review(s) available for latrepirdine and Protein Aggregation, Pathological
| Article | Year |
|---|---|
[Latrepirdine: a systematic review of the preclinical studies].
Topics: Animals; Biological Availability; Calcium Signaling; Cholinesterase Inhibitors; Disease Models, Animal; Drug Evaluation, Preclinical; Excitatory Amino Acid Antagonists; Humans; Indoles; Mice; Mitochondria; Molecular Structure; Motor Neurons; Neurodegenerative Diseases; Neurons; Neuroprotective Agents; Parkinsonian Disorders; Protein Aggregation, Pathological; Rabbits; Rats; Receptors, N-Methyl-D-Aspartate; Tissue Distribution | 2015 |
Novel Sites of Neuroprotective Action of Dimebon (Latrepirdine).
Topics: Animals; Autophagy; DNA-Binding Proteins; Excitatory Amino Acid Antagonists; Female; Humans; Indoles; Mice; Mutation; Nerve Tissue Proteins; Neurodegenerative Diseases; Neuroprotective Agents; Protein Aggregation, Pathological; Recombinant Fusion Proteins; RNA-Binding Protein FUS | 2015 |